178 related articles for article (PubMed ID: 1797337)
1. Interleukin-8 as a mediator of sympathetic pain.
Cunha FQ; Lorenzetti BB; Poole S; Ferreira SH
Br J Pharmacol; 1991 Nov; 104(3):765-7. PubMed ID: 1797337
[TBL] [Abstract][Full Text] [Related]
2. Cytokine-induced neutrophil chemoattractant 1 (CINC-1) mediates the sympathetic component of inflammatory mechanical hypersensitivitiy in rats.
Lorenzetti BB; Veiga FH; Canetti CA; Poole S; Cunha FQ; Ferreira SH
Eur Cytokine Netw; 2002; 13(4):456-61. PubMed ID: 12517731
[TBL] [Abstract][Full Text] [Related]
3. The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia.
Cunha FQ; Poole S; Lorenzetti BB; Ferreira SH
Br J Pharmacol; 1992 Nov; 107(3):660-4. PubMed ID: 1472964
[TBL] [Abstract][Full Text] [Related]
4. Bradykinin initiates cytokine-mediated inflammatory hyperalgesia.
Ferreira SH; Lorenzetti BB; Poole S
Br J Pharmacol; 1993 Nov; 110(3):1227-31. PubMed ID: 8298813
[TBL] [Abstract][Full Text] [Related]
5. A peripheral sympathetic component in inflammatory hyperalgesia.
Nakamura M; Ferreira SH
Eur J Pharmacol; 1987 Mar; 135(2):145-53. PubMed ID: 2884117
[TBL] [Abstract][Full Text] [Related]
6. Tumour necrosis factor-alpha, interleukin-1beta and interleukin-8 induce persistent mechanical nociceptor hypersensitivity.
Sachs D; Cunha FQ; Poole S; Ferreira SH
Pain; 2002 Mar; 96(1-2):89-97. PubMed ID: 11932065
[TBL] [Abstract][Full Text] [Related]
7. Involvement of bradykinin, cytokines, sympathetic amines and prostaglandins in formalin-induced orofacial nociception in rats.
Chichorro JG; Lorenzetti BB; Zampronio AR
Br J Pharmacol; 2004 Apr; 141(7):1175-84. PubMed ID: 15006904
[TBL] [Abstract][Full Text] [Related]
8. Nociceptive effect of subcutaneously injected interleukin-12 is mediated by endothelin (ET) acting on ETB receptors in rats.
Verri WA; Molina RO; Schivo IR; Cunha TM; Parada CA; Poole S; Ferreira SH; Cunha FQ
J Pharmacol Exp Ther; 2005 Nov; 315(2):609-15. PubMed ID: 16024732
[TBL] [Abstract][Full Text] [Related]
9. Peripheral sympathetic component of the temporomandibular joint inflammatory pain in rats.
Rodrigues LL; Oliveira MC; Pelegrini-da-Silva A; de Arruda Veiga MC; Parada CA; Tambeli CH
J Pain; 2006 Dec; 7(12):929-36. PubMed ID: 17157779
[TBL] [Abstract][Full Text] [Related]
10. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-10.
Poole S; Cunha FQ; Selkirk S; Lorenzetti BB; Ferreira SH
Br J Pharmacol; 1995 Jun; 115(4):684-8. PubMed ID: 7582491
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterisation of the somatostatin analogue TT-232: effects on neurogenic and non-neurogenic inflammation and neuropathic hyperalgesia.
Pintér E; Helyes Z; Németh J; Pórszász R; Pethö G; Thán M; Kéri G; Horváth A; Jakab B; Szolcsányi J
Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):142-50. PubMed ID: 12122501
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 beta as a potent hyperalgesic agent antagonized by a tripeptide analogue.
Ferreira SH; Lorenzetti BB; Bristow AF; Poole S
Nature; 1988 Aug; 334(6184):698-700. PubMed ID: 3137474
[TBL] [Abstract][Full Text] [Related]
13. Role of lipocortin-1 in the anti-hyperalgesic actions of dexamethasone.
Ferreira SH; Cunha FQ; Lorenzetti BB; Michelin MA; Perretti M; Flower RJ; Poole S
Br J Pharmacol; 1997 Jul; 121(5):883-8. PubMed ID: 9222544
[TBL] [Abstract][Full Text] [Related]
14. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist.
Cunha JM; Cunha FQ; Poole S; Ferreira SH
Br J Pharmacol; 2000 Jul; 130(6):1418-24. PubMed ID: 10903985
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological modulation of secondary mediator systems--cyclic AMP and cyclic GMP--on inflammatory hyperalgesia.
Cunha FQ; Teixeira MM; Ferreira SH
Br J Pharmacol; 1999 Jun; 127(3):671-8. PubMed ID: 10401557
[TBL] [Abstract][Full Text] [Related]
16. A novel mechanism involved in 5-hydroxytryptamine-induced nociception: the indirect activation of primary afferents.
Tambeli CH; Oliveira MC; Clemente JT; Pelegrini-da-Silva A; Parada CA
Neuroscience; 2006 Sep; 141(3):1517-24. PubMed ID: 16750893
[TBL] [Abstract][Full Text] [Related]
17. Endogenous opioids mediate the hypoalgesia induced by selective inhibitors of cyclo-oxygenase 2 in rat paws treated with carrageenan.
França DS; Ferreira-Alves DL; Duarte ID; Ribeiro MC; Rezende RM; Bakhle YS; Francischi JN
Neuropharmacology; 2006 Jul; 51(1):37-43. PubMed ID: 16620880
[TBL] [Abstract][Full Text] [Related]
18. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-4.
Cunha FQ; Poole S; Lorenzetti BB; Veiga FH; Ferreira SH
Br J Pharmacol; 1999 Jan; 126(1):45-50. PubMed ID: 10051119
[TBL] [Abstract][Full Text] [Related]
19. Involvement of interleukin-1 beta, nerve growth factor, and prostaglandin-E2 in the hyperalgesia induced by intraplantar injections of low doses of thymulin.
Safieh-Garabedian B; Kanaan SA; Jalakhian RH; Jabbur SJ; Saadé NE
Brain Behav Immun; 1997 Sep; 11(3):185-200. PubMed ID: 9417804
[TBL] [Abstract][Full Text] [Related]
20. Inhibition by neuropeptides of interleukin-1 beta-induced, prostaglandin-independent hyperalgesia.
Follenfant RL; Nakamura-Craig M; Henderson B; Higgs GA
Br J Pharmacol; 1989 Sep; 98(1):41-3. PubMed ID: 2804553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
